Related Experiment Video
Updated: Jul 7, 2025
08:45
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
2.4K
RNA m6A methylation in psychiatric disorders.
Qiao Mao1, Jessica Luo2, Xinqun Luo3
1Department of Psychosomatic Medicine, People's Hospital of Deyang City, Deyang, Sichuan 618000, China.
EC Psychology and Psychiatry
|December 25, 2023
Summary
This review explores N6-methyladenosine (m6A) modification and its crucial role in neuropsychiatric disorders like Alzheimer's disease. m6A regulators show promise as diagnostic and therapeutic targets for these conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- N6-methyladenosine (m6A) is the most prevalent internal mRNA modification.
- m6A modification plays vital roles in various biological processes, including neurological functions.
- Dysregulation of m6A is implicated in the pathogenesis of numerous diseases.
Purpose of the Study:
- To review the features of m6A modification.
- To elucidate the role of m6A modification and its regulators in neuropsychiatric disorders.
- To identify potential diagnostic and therapeutic targets for these conditions.
Main Methods:
- Comprehensive literature review of m6A modification.
- Analysis of research findings on m6A regulators in psychiatric disorders.
- Focus on the involvement of m6A in Alzheimer's disease pathogenesis.
Main Results:
- m6A modification and its regulators are critical in the development of major psychiatric disorders.
- These modifications impact synaptic protein synthesis, immune infiltration, and pathogenesis.
- METTL3, an m6A methyltransferase, is a key regulator identified in these diseases.
Conclusions:
- m6A regulators are potential novel diagnostic and therapeutic targets for neuropsychiatric disorders.
- m6A modification presents a promising avenue for the prevention and treatment of major psychiatric disorders.
- Further research into m6A pathways could unlock new treatment strategies.
Related Concept Videos
01:46Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
01:28Human Genetics
581
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
581
01:30Attention-Deficit/Hyperactivity Disorder
68
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
01:17Phase II Reactions: Methylation Reactions
193
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
193
01:29Biological Causes of Schizophrenia
58
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
58
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
673
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
673